Essa Pharma Inc.
SEC CIK 1633932 · EPIX · last insider filing 2025-10-15
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Berger Franklin M | Director | filed 2020 - 2025 |
| Glickman Richard M | Director | filed 2020 - 2025 |
| Parkinson David Ross | Director · President and CEO | filed 2020 - 2025 |
| Martin John Alexander | Director | filed 2020 - 2025 |
| Requadt Scott | Director | filed 2020 - 2025 |
| Thorell Marella | Director | filed 2020 - 2025 |
| Zweifach Sanford S | Director | filed 2020 - 2024 |
| Sollis Gary | Director | filed 2020 - 2024 |
| Merendino Lauren | Director | filed 2023 - 2024 |
| Kantoff Philip W. | Director | filed 2022 - 2024 |
| Brettman Ari David | Director | filed 2020 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Wood David S. | Chief Financial Officer | filed 2020 - 2025 |
| Virsik Peter | Chief Operating Officer | filed 2020 - 2024 |
| Cesano Alessandra | Chief Medical Officer | filed 2020 - 2024 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.